Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin.

In vivo studies using NSCLC xenograft models demonstrated that oral gavage administration of silibinin at 100 mg/kg body weight caused highly significant decreases in tumor volume as compared to NSCLC fed controls.

also in 132,142 other papers